Peter Libby: Inflammation and Traditional Risk Factors Work Together in Cardiovascular Disease
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Women’s Hospital, reposted from International Atherosclerosis Society on LinkedIn:
”Informative new vignettes about Inflammation and Cardiovascular Disease. Inflammation and traditional risk factors work together!
The title echoes a paper I did a few years ago: Strandberg TE, Libby P, Kovanen PT. A tale of two therapies lipid-lowering vs. anti-inflammatory therapy: a false dichotomy? Cardiovasc Pharmacol 2021;7(3):238-241. ”
Qutoing International Atherosclerosis Society‘s post:
”It’s Inflammation Monday!
Every Monday, IAS will be highlighting the recordings of the live lectures from the Inflammation Academy, held in Madrid on August 28, 2025.
For the first lecture highlight, hear from Peter Libby, MD, as he speaks on how inflammatory mechanisms link traditional risk factors to adverse cardiovascular events.
Watch to learn more.”
Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis